View Older Stories View More Recent Stories
-
PlacementTracker Publishes 2016 Private Placement Market League Tables
-
Roth Capital Starts TPI Composites (TPIC) at Buy
-
PIPE Deals Positioned to Soar in 2017 with Trump Deregulation Gift
-
Pre-Open Stock Movers 01/11: (BIOC) (DSCI) (ENPH) Higher; (NVDQ) (ETH) (SIG) Lower (more...)
-
Roth Capital Downgrades Himax Technologies (HIMX) to Neutral
-
Roth Capital Starts Polar Power (POLA) at Buy
-
Mast Therapeutics (MSTX) to Merge with Savara
-
Mast Therapeutics And Savara Sign Merger Agreement
-
ROTH Capital Partners appoints Michael Margolis, R.Ph. as Head of Healthcare Investment Banking
-
MaxLinear, Inc. to Present at Upcoming Financial Conferences
-
Pre-Open Stock Movers 01/04: (EVOK) (CBAY) (OCUL) Higher; (AGRX) (ACUR) (ENSG) Lower (more...)
-
Roth Capital Starts Kite Pharma (KITE) at Buy
-
Roth Capital Starts Paramount Gold and Silver (PZG) at Buy
-
After-Hours Stock Movers 01/03: (CBAY) (SHAK) (CC) Higher; (AGRX) (ACUR) (TSLA) Lower (more...)
-
Acura Pharma (ACUR) Exploring Strategic Options, Including Possible Sale
-
Acura Pharmaceuticals Exploring Strategic Alternatives
-
RedHill Biopharma Announces Exercise of Underwriters' Option
-
RedHill Biopharma Announces Exercise of Underwriters’ Option
-
Roth Capital Starts SenesTech (SNES) at Buy
-
Roth Capital Starts Ameresco (AMRC) at Neutral
-
RedHill Biopharma Announces Closing of Concurrent Public Offering and Registered Direct Offering of its American Depositary Shares and Warrants and Partial Exercise of the Option of Underwriters
-
RedHill Biopharma Announces Closing of Concurrent Public Offering and Registered Direct Offering of its American Depositary Shares and Warrants and Partial Exercise of the Option of Underwriters
-
NeuroDerm Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Roth Capital Starts LightPath Technologies (LPTH) at Buy
-
LightPath Technologies Completes Acquisition of ISP Optics Corporation
-
Roth Capital Downgrades InvenSense (INVN) to Neutral
-
RedHill Biopharma (RDHL) Prices Common Stock, Warrant Offering
-
RedHill Biopharma Prices Concurrent Public Offering and Registered Direct Offering of its American Depositary Shares and Warrants
-
Roth Capital Starts IRIDEX Corp (IRIX) at Buy
-
RedHill Biopharma (RDHL) Plans to Offer ADSs and Warrants
-
RedHill Biopharma Announces Proposed Concurrent Public Offering and Registered Direct Offering of its American Depositary Shares and Warrants
-
RedHill Biopharma Announces Proposed Concurrent Public Offering and Registered Direct Offering of its American Depositary Shares and Warrants
-
ROTH Capital Partners Honored by Global M&A Network and M&A Advisor
-
US Energy (USEG) Prices Direct Offering at $1.50/Share
-
U.S. Energy Corp. To Raise $1.5 Million In Registered Direct Offering
-
Recro Pharma Announces Closing of $40 Million Public Offering of Common Stock
-
Lonestar Resources US, Inc. (LONE) Prices 12M Share Offering
-
Lonestar Resources US Inc. Announces Pricing of Public Offering of Common Stock
-
Lightpath Technologies (LPTH) Prices 7M Stock Offering at $1.21 Per Share
-
LightPath Technologies Prices Underwritten Public Offering of Class A Common Stock
-
Hudson Technologies, Inc. Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares
-
SenesTech, Inc. Announces Closing of Initial Public Offering
-
RGS Energy Completes $4.1 Million Public Offering of Common Stock and Warrants
-
Recro Pharma (REPH) Prices 6.5M Shares at $6/Share
-
Recro Pharma Announces Pricing of Public Offering of Common Stock
-
Roth Capital Starts Roka Bioscience (ROKA) at Buy, PT $10
-
Polar Power Announces Closing of Initial Public Offering and Exercise of Over-Allotment Option
-
NeuroDerm Announces Closing of a Follow-On Offering of Ordinary Shares
-
Roth Capital Starts Ritter Pharmaceuticals (RTTR) at Buy
-
Ring Energy, Inc. Announces Completion of Public Offering of Common Stock
